Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
American Heart Journal|April 13, 2004
Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromesJ P Collet, G Montalescot, J L Golmard, et al.
Circulation|July 16, 2003
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortalityJ P Collet, G Montalescot, E Vicaut, et al.
Thrombosis and Haemostasis|August 9, 2013
Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assayJ Abtan, J Silvain, M Kerneis, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 5, 2002
[Value of combined coronary angioplasty and coronary angiography]E Fonseca, C Le Feuvre, G Helft, et al.
Archives of Cardiovascular Diseases|July 26, 2008
Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stentsC Le Feuvre, G Helft, S Cohen, et al.
Annales De Cardiologie Et D'Angeiologie|August 27, 2003
[Clopidogrel and thrombopenia. A case report]G Helft, I Elalamy, C Laudy, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 18, 1999
[New thrombolytic agents in myocardial infarction]G Helft, I Elalamy, F Beygui, et al.
International Journal of Cardiology|July 17, 2012
Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD StudyO Barthélémy, G Cayla, J Silvain, et al.
Heart (British Cardiac Society)|March 23, 2011
Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD StudyG Cayla, J Silvain, O Barthelemy, et al.
Circulation|October 13, 2004
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromesJ P Collet, G Montalescot, B Blanchet, et al.
Pageof 4